Australia's Rhythm Biosciences jumps on establishing unit in UK

Rhythm Biosciences

03/07/2023 03:20

** Shares of Rhythm Biosciences  RHY.AX  rise as much as
20.7% to A$0.495, its highest level since June 16
    ** Stock set to mark best day since May 17, if gains hold
    ** Co says it has established a fully-owned subsidiary,
Rhythm Biosciences UK Limited
    ** Adds local presence in the UK will provide co the
opportunity to engage directly with local customers and a direct
involvement with supply chain requirements of the drug ColoSTAT
    ** Stock has fallen 58.6% this year, as of last close

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))